Skip to main content

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

Abstract

Idiopathic orbital inflammation is an inflammatory process of the orbit and ocular adnexa without local or systemic etiology. It is the second or third most common orbital tumor. Idiopathic orbital inflammation can affect any race, age, and sex, with peak incidence at middle ages. It is usually a unilateral disease with almost equal involvement of the right and left orbits. Patients most commonly complain of pain (58–69 %) and diplopia (31–38 %) and present with periorbital swelling (75–79 %), proptosis (32–63 %), restriction in extraocular motility (54 %), and conjunctival hyperemia (48 %). It is classified as acute, subacute, and chronic based on the onset and duration of symptoms; dacryoadenitis, myositis, scleritis, perineuritis, and Tolosa-Hunt syndrome based on the involved tissue; and lymphocytic, granulomatous, sclerosing, and vasculitic inflammation based on pathologic features. Cytokines important in the induction of Th1 pathway are found to be increased in idiopathic orbital inflammation. This suggests the role of Th1 pathway in the pathogenesis. Toll-like receptors 2 are markedly expressed, supporting the role of innate immune system. The diagnosis is usually based on clinical and radiologic findings; however, biopsy is required to confirm the diagnosis. On computed tomography, it shows diffuse homogenous involvement of the orbital tissue. Histopathologic examination shows infiltrate of inflammatory cells of well-differentiated mature lymphocytes, admixed with plasma cells, neutrophils, and eosinophils. The management includes observation in asymptomatic patients and nonsteroidal anti-inflammatory agents in selected cases. Corticosteroids are the main treatment option with rapid and dramatic response. Immunosuppressive agents are used for patients who are unresponsive to corticosteroid or have a chronic, progressive course and require long-term treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gleason JE. Idiopathic myositis involving the extraocular muscles. Ophthalmic Rec. 1903;12:471–8.

    Google Scholar 

  2. Birch-Hirschfeld A. Zur diagnostic and pathologic der orbital tumoren. Ber zusammenkunft Dtsch Ophthalmol Ges. 1905;32:127–35.

    Google Scholar 

  3. Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology. 2004;111:997–1008.

    Article  PubMed  Google Scholar 

  4. Yuen SJ, Rubin PA. Idiopathic orbital inflammation. Distribution, clinical features and treatment outcome. Arch Ophthalmol. 2003;121:491–9.

    Article  PubMed  Google Scholar 

  5. Rubin PA, Foster CS. Etiology and management of idiopathic orbital inflammation. Am J Ophthalmol. 2004;138:1041–3.

    Article  PubMed  Google Scholar 

  6. Garrity JA, Henderson JW. The tumor surgery in the Henderson’s orbital tumors. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 23–32.

    Google Scholar 

  7. Gordon LK. Orbital inflammatory disease: a diagnostic and therapeutic challenge. Eye (London). 2006;20:1196–206.

    Article  CAS  Google Scholar 

  8. Kitei D, DiMario Jr FJ. Childhood orbital pseudotumor: case report and literature review. J Child Neurol. 2008;23:425–30.

    Article  PubMed  Google Scholar 

  9. Scott IU, Siatkowski RM. Idiopathic orbital myositis. Curr Opin Rheumatol. 1997;9:504–12.

    Article  CAS  PubMed  Google Scholar 

  10. Siatkowski RM, Capo H, Byrne SF, et al. Clinical and echographic findings in idiopathic orbital myositis. Am J Ophthalmol. 1994;118:343–50.

    Article  CAS  PubMed  Google Scholar 

  11. Mendenhall WM, Lessner AM. Orbital pseudotumor. Am J Clin Oncol. 2010;33:304–6.

    Article  PubMed  Google Scholar 

  12. Yan J, Wu Z, Li Y. The differentiation of idiopathic inflammatory pseudotumor from lymphoid tumors of orbit: analysis of 319 cases. Orbit. 2004;23:245–54.

    Article  PubMed  Google Scholar 

  13. Berger JW, Rubin PA, Jakobiec FA. Pediatric orbital pseudotumor: case report and review of the literature. Int Ophthalmol Clin. 1996;36(1):161–77.

    Article  CAS  PubMed  Google Scholar 

  14. Mottow-Lippa L, Jakobiec FA, Smith M. Idiopathic inflammatory orbital pseudotumor in childhood II. Results of diagnostic tests and biopsies. Ophthalmology. 1981;88:565–74.

    Article  CAS  PubMed  Google Scholar 

  15. Belanger C, Zhang KS, Reddy AK, Yen MY, Yen KG. Inflammatory disorders of the orbit in childhood: a case series. Am J Ophthalmol. 2010;150:460–3.

    Article  PubMed  Google Scholar 

  16. Gupta S, Demirci H, Lee BJ, Elner VM, Kahana A, et al. Orbital inflammation. In: Smith and Nesi’s ophthalmic plastic and reconstructive surgery. New York: Springer; 2012. pp.

    Google Scholar 

  17. Rootman J. Inflammatory diseases. In: Rootman J, editor. Diseases of the orbit: a multidisciplinary approach. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2003. p. 455–506.

    Google Scholar 

  18. Cockerham KP, Hong SH, Browne EE. Orbital inflammation. Curr Neurol Neurosci Rep. 2003;3(5):401–9.

    Article  PubMed  Google Scholar 

  19. Weber AL, Jakobiec FA, Sabates NR. Pseudotumor of the orbit. Neuroimaging Clin N Am. 1996;6(1):73–92.

    CAS  PubMed  Google Scholar 

  20. Chaudhry IA, Shamsi FA, Arat YO, Riley FC. Orbital pseudotumor: distinct diagnostic features and management. Middle East Afr J Ophthalmol. 2008;15:17–27.

    Article  PubMed  Google Scholar 

  21. Gunalp I, Gunduz K, Yazar Z. Idiopathic orbital inflammatory disease. Acta Ophthalmol Scand. 1996;74:191–3.

    Article  CAS  PubMed  Google Scholar 

  22. Zborowska B, Ghabrial R, Selva D, McCluskey P. Idiopathic orbital inflammation with extraorbital extension: case series and review. Eye (London). 2006;20:107–13.

    Article  CAS  Google Scholar 

  23. Tay E, Gibson A, Chaudhary N, Olver J. Idiopathic orbital inflammation with extensive intra- and extracranial extension presenting as 6th nerve palsy – a case report and literature review. Orbit. 2008;27:458–61.

    Article  PubMed  Google Scholar 

  24. de Jesus O, Inserni JA, Gonzalez A, Colon LE. Idiopathic orbital inflammation with intracranial extension. Case report. J Neurosurg. 1996;85:510–3.

    Article  PubMed  Google Scholar 

  25. Cruz AA, Akaishi PM, Chahud F, Elias JJ. Sclerosing inflammation in the orbit and in the pterygopalatine and infratemporal fossae. Ophthal Plast Reconstr Surg. 2003;19:201–6.

    Article  PubMed  Google Scholar 

  26. Kaye AH, Hahn JF, Craciun A, Hanson M, Berlin AJ, Tubbs RR. Intracranial extension of inflammatory pseudotumor of the orbit. Case report. J Neurosurg. 1984;60:625–9.

    Article  CAS  PubMed  Google Scholar 

  27. Bencherif B, Zouaoui A, Chedid G, Kujas M, Van Effenterre R, Marsault C. Intracranial extension of an idiopathic orbital inflammatory pseudotumor. AJNR Am J Neuroradiol. 1993;14:181–4.

    CAS  PubMed  Google Scholar 

  28. Noble SC, Chandler WF, Lloyd RV. Intracranial extension of orbital pseudotumor: a case report. Neurosurgery. 1986;18:798–801.

    Article  CAS  PubMed  Google Scholar 

  29. Frohman LP, Kupersmith MJ, Lang J, et al. Intracranial extension and bone destruction in orbital pseudotumor. Arch Ophthalmol. 1986;104:380–4.

    Article  CAS  PubMed  Google Scholar 

  30. Mombaerts I, Goldschmeding R, Schlingemann RO, Koorneef L. What is orbital pseudotumor? Surv Ophthalmol. 1996;41:66–78.

    Article  CAS  PubMed  Google Scholar 

  31. Bijlsma WR, Vant Hullenaar FC, Mourits MP, Kalmann R. Evaluation of classification systems for nonspecific idiopathic orbital inflammation. Orbit. 2012;31:238–45.

    Article  PubMed  Google Scholar 

  32. Purcell JJ, Taulbee WA. Orbital myositis after upper respiratory tract infection. Arch Ophthalmol. 1981;99:437–8.

    Article  PubMed  Google Scholar 

  33. Nieto JC, Kim N, Lucarelli MJ. Dacryoadenitis and orbital myositis associated with lyme disease. Arch Ophthalmol. 2008;126:1165–6.

    Article  PubMed  Google Scholar 

  34. Kawasaki A, Borruat FX. An unusual presentation of herpes zoster ophthalmicus: orbital myositis preceding vesicular eruption. Am J Ophthalmol. 2003;136:574–5.

    Article  PubMed  Google Scholar 

  35. Alshaikh M, Kakakios AM, Kemp AS. Orbital myositis following streptococcal pharyngitis. J Paediatr Child Health. 2008;44:233–4.

    Article  PubMed  Google Scholar 

  36. Wirostko E, Johnson L, Wirostko B. Chronic orbital inflammatory disease: parasitisation of orbital leukocytes by mollicute-like organisms. Br J Ophthalmol. 1989;73:865–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Sobrin L, Kim E, Christen W, et al. Infliximab therapy for the treatment of refractory ocular inflammatory disease. Arch Ophthalmol. 2007;125:895–900.

    Article  CAS  PubMed  Google Scholar 

  38. Garrity JA, Coleman AW, Matteson EL, et al. Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab. Am J Ophthalmol. 2004;138:925–30.

    Article  CAS  PubMed  Google Scholar 

  39. Atabay C, Tyutyunikov A, Scalise D, et al. Serum antibodies reactive with eye muscle membrane antigens are detected in patients with nonspecific orbital inflammation. Ophthalmology. 1995;102:145–53.

    Article  CAS  PubMed  Google Scholar 

  40. Wladis EJ, Iglesias BV, Gosselin EJ. Characterization of the molecular biologic milieu of idiopathic orbital inflammation. Ophthal Plast Reconstr Surg. 2011;27:251.

    Article  PubMed  Google Scholar 

  41. Wladis EJ, Iglesias BV, Adam AP, Nazeer T, Gosslein EJ. Toll-like receptors in idiopathic orbital inflammation. Ophthal Plast Reconstr Surg. 2012;28:273–6.

    Article  PubMed  Google Scholar 

  42. De Wyngaert R, Casteels I, Demaerel P. Orbital and anterior visual pathway infection and inflammation. Neuroradiology. 2009;51:385–96.

    Article  PubMed  Google Scholar 

  43. Kapur R, Sepahdari AR, Mafee MF, et al. MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging. AJNR Am J Neuroradiol. 2009;30:64–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Ben Simon GJ, Syed HM, Douglas R, McCann JD, Goldberg RA. Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy. Am J Ophthalmol. 2004;137:1145–7.

    Article  PubMed  Google Scholar 

  45. Mauriello Jr JA, Flanagan JC. Management of orbital inflammatory disease. A protocol. Surv Ophthalmol. 1984;29:104–16.

    Article  PubMed  Google Scholar 

  46. Kennerdell JS, Dresner SC. The nonspecific orbital inflammatory syndromes. Surv Ophthalmol. 1984;29:93–103.

    Article  CAS  PubMed  Google Scholar 

  47. Swamy BN, McCluskey P, Nemet A, Crouch R, Martin P, Benger R, Ghabriel R, Wakefield D. Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes. Br J Ophthalmol. 2007;91:1667–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. McCarthy JM, White VA, Harris G, et al. Idiopathic sclerosing inflammation of the orbit: immunohistologic analysis and comparison with retroperitoneal fibrosis. Mod Pathol. 1993;6:581–7.

    CAS  PubMed  Google Scholar 

  49. Ho VH, Chevez-Barrios P, Jorgensen JL, Silkis RZ, Esmaeli B. Receptor expression in orbital inflammatory syndromes and implications for targeted therapy. Tissue Antigens. 2007;70:105–9.

    Article  CAS  PubMed  Google Scholar 

  50. Jakobiec FA, Font RL. Noninfectious orbital inflammations. In: Spence WH, editor. Ophthalmic pathology: an atlas and textbook, vol. 3. 3rd ed. Philadelphia: WB Saunders; 1986. p. 2777–95.

    Google Scholar 

  51. Rootman J, McCarthy M, White V, et al. Idiopathic sclerosing inflammation of the orbit. A distinct clinicopathological entity. Ophthalmology. 1994;101:570–84.

    Article  CAS  PubMed  Google Scholar 

  52. Nogushi H, Kephart GM, Campbell J, et al. Tissue eosinophilia and eosinophil degranulation in orbital pseudotumor. Ophthalmology. 1991;98:928–32.

    Article  Google Scholar 

  53. Raskin EM, McCormick S, Maher EA, Della Rocca RC. Granulomatous idiopathic orbital inflammation. Ophthal Plast Reconstr Surg. 1995;11:131–5.

    Article  CAS  PubMed  Google Scholar 

  54. Mombaerts I, Schlingemann RO, Gold.schmeding R, Koornneef L. Idiopathic granulomatous orbital inflammation. Ophthalmology. 1996;103:2135–41.

    Article  CAS  PubMed  Google Scholar 

  55. Pemberton JD, Fay A. Idiopathic sclerosing orbital inflammation: a review of demographics, clinical presentation, imaging, pathology, treatment, and outcome. Ophthal Plast Reconstr Surg. 2012;28:79–83.

    Article  PubMed  Google Scholar 

  56. Levine MR, Kaye L, Mair S, Bates J. Multifocal fibrosclerosis. Report of a case of bilateral idiopathic sclerosing pseudotumor and retroperitoneal fibrosis. Arch Ophthalmol. 1993;111:841–3.

    Article  CAS  PubMed  Google Scholar 

  57. Comings DE, Skubi KB, Van Eyes J, Motulsky AG. Familial multifocal fibrosclerosis. Findings suggesting that retroperitoneal fibrosis, mediastinal fibrosis, sclerosing cholangitis, Riedel’s thyroiditis, and pseudotumor of the orbit may be different manifestations of a single disease. Ann Intern Med. 1967;66:884–92.

    Article  CAS  PubMed  Google Scholar 

  58. Egsgaard Nielsen V, Hecht P, Krogdahl AS, et al. A rare case of orbital involvement in Riedel’s thyroiditis. J Endocrinol Invest. 2003;26:1032–6.

    Article  CAS  PubMed  Google Scholar 

  59. Schaffler GJ, Simbrunner J, Lechner H, et al. Idiopathic sclerotic inflammation of the orbit with left optic nerve compression in a patient with multifocal fibrosclerosis. AJNR Am J Neuroradiol. 2000;21:194–7.

    CAS  PubMed  Google Scholar 

  60. Hsuan JD, Selva D, McNab AA, Sullivan TJ, Saeed P, O’Donnell BA. Idiopathic sclerosing orbital inflammation. Arch Ophthalmol. 2006;124:1244–50.

    Article  PubMed  Google Scholar 

  61. Chen YM, Hu FR, Liao SL. Idiopathic sclerosing orbital inflammation – a case series study. Ophthalmologica. 2010;224:55–8.

    Article  PubMed  Google Scholar 

  62. Espinoza GM. Orbital inflammatory pseudotumors: etiology, differential diagnosis, and management. Curr Rheumatol Rep. 2010;12:443–7.

    Article  PubMed  Google Scholar 

  63. Mawn LA, Jordan DR, Donahue SP. Preseptal and orbital cellulitis. Ophthalmol Clin North Am. 2000;13:633–41.

    Article  Google Scholar 

  64. Cockerham KP, Chan SS. Thyroid eye disease. Neurol Clin. 2010;28:729–55.

    Article  PubMed  Google Scholar 

  65. Briceno CA, Guspta S, Douglas RS. Advances in the management of thyroid eye disease. Int Ophthalmol Clin. 2013;53:93–101.

    Article  PubMed Central  PubMed  Google Scholar 

  66. Watkins LM, Carter KD, Nerad JA. Ocular adnexal lymphoma of the extraocular muscles: case series from the University of Iowa and review of the literature. Ophthal Plast Reconstr Surg. 2011;27:471–6.

    Article  PubMed  Google Scholar 

  67. Mannor GE, Rose GE, Moseley IF, Wright JE. Outcome of orbital myositis. Clinical features associated with recurrence. Ophthalmology. 1997;104:409–13.

    Article  CAS  PubMed  Google Scholar 

  68. Mombaerts I, Schlingemann RO, Goldschmeding R, Koornneef L. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology. 1996;103:521–8.

    Article  CAS  PubMed  Google Scholar 

  69. Jacobs D, Galetta S. Diagnosis and management of orbital pseudo- tumor. Curr Opin Ophthalmol. 2002;13(6):347–51.

    Article  PubMed  Google Scholar 

  70. Harris GJ. Idiopathic orbital inflammation: a pathogenetic construct and treatment strategy: the 2005 ASOPRS foundation lecture. Ophthal Plast Reconstr Surg. 2006;22:79–86.

    Article  PubMed  Google Scholar 

  71. Bijlsma WR, Paridaens D, Kalmann R. Treatment of severe idiopathic orbital inflammation with intravenous methylprednisolone. Br J Ophthalmol. 2011;95:1068–71.

    Article  PubMed  Google Scholar 

  72. Leibovitch I, Prabhakaran VC, Davis G, Selva D. Intraorbital injection of triamcinolone acetonide in patients with idiopathic orbital inflammation. Arch Ophthalmol. 2007;125:1647–51.

    Article  CAS  PubMed  Google Scholar 

  73. Skaat A, Rosen N, Rosner M, Schiby G, Simon GJ. Triamcinolone acetonide injection for persistent atypical idiopathic orbital inflammation. Orbit. 2009;28:401–3.

    Article  PubMed  Google Scholar 

  74. Orcutt J, Garner A, Henk J, Wright J. Treatment of idiopathic inflammatory orbital pseudotumors by radiotherapy. Br J Ophthalmol. 1983;67:570–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  75. Kennerdell J, Johnson B, Deutsch M. Radiation treatment of orbital lymphoid hyperplasia. Ophthalmology. 1979;86:942–7.

    Article  CAS  PubMed  Google Scholar 

  76. Sergott R, Glaser J, Charyulu K. Radiotherapy for idiopathic inflammatory orbital pseudotumor: indications and results. Arch Ophthalmol. 1981;99:8536.

    Article  Google Scholar 

  77. Lanciano R, Fowble B, Sergoot RC, et al. The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys. 1990;18:407–11.

    Article  CAS  PubMed  Google Scholar 

  78. Snebold NG. Orbital pseudotumor syndromes. Curr Opin Ophthalmol. 1997;8:41–4.

    Article  CAS  PubMed  Google Scholar 

  79. Garrity JA, Kennerdell JS, Johnson B, et al. Cyclophosphamide in the treatment of orbital vasculitis. Am J Ophthalmol. 1986;102:97–103.

    Article  CAS  PubMed  Google Scholar 

  80. Zacharopoulos IP, Papadaki T, Manor RS, Briscoe D. Treatment of idiopathic orbital inflammatory disease with cyclosporine-A: a case presentation. Semin Ophthalmol. 2009;24:260–1.

    Article  PubMed  Google Scholar 

  81. Osborne SF, Sims JL, Rosser PM. Short-term use of Infliximab in a case of recalcitrant idiopathic orbital inflammatory disease. Clin Experiment Ophthalmol. 2009;37:897–900.

    Article  PubMed  Google Scholar 

  82. Smith JR, Rosenbaum JT. A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol. 2001;85:1220–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  83. Hatton MP, Rubin PA, Foster CS. Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil. Am J Ophthalmol. 2005;140(5):916–8.

    Article  CAS  PubMed  Google Scholar 

  84. Eagle K, King A, Fisher C, Souhami R. Cyclophosphamide induced remission in relapsed, progressive idiopathic orbital inflammation (‘Pseudotumour’). Clin Oncol (R Coll Radiol). 1995;7:402–4.

    Article  CAS  Google Scholar 

  85. Shah SS, Lowder CY, Schmitt MA, Wilke WS, Kosmorsky GS, Meisler DM. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology. 1992;99:1419–23.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethical Requirements

Hakan Demirci declares that he has no conflict of interest.

No human or animal studies were carried out by the authors for this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hakan Demirci MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Demirci, H. (2015). Idiopathic Orbital Inflammation. In: Demirci, H. (eds) Orbital Inflammatory Diseases and Their Differential Diagnosis. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46528-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46528-8_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46527-1

  • Online ISBN: 978-3-662-46528-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics